NASDAQ:FULC Shareholder Notice: Investigation over Possible Securities Laws Violations by Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
View full press release